Moderna Aces COVID-19 Vaccine Results With 94.5% Efficacy
Outperforms Pfizer At First Analysis
Moderna’s stunning interim results add to the world’s relief brought by Pfizer’s first read-out, and also provide the US biotech with the commercial platform it needed
